← All indications
Hypobetalipoproteinemias
Conditions with abnormally low levels of BETA-LIPOPROTEINS (low density lipoproteins or LDL) in the blood. It is defined as LDL values equal to or less than the 5th percentile for the population. They include the autosomal dominant form involving mutation of the APOLIPOPROTEINS B gene, and the autosomal recessive form involving mutation of the microsomal triglyceride transfer protein. All are characterized by low LDL and dietary fat malabsorption.
Subtype terms (2)
More specific conditions that are subtypes of Hypobetalipoproteinemias in the MeSH hierarchy.
Drugs by status
Phase 3 trials (1)
Phase 2 trials (1)
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (3)